Physician profile
Htwe H Sein
NPI 1376584185
$11,102.58
in general payments reported to CMS, 2019-2025
47 companies · $1,700 in 2025
The $1,700 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,936 · 2020: $978 · 2021: $1,633 · 2022: $1,656 · 2023: $1,302 · 2024: $1,897 · 2025: $1,700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,898.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,532.01 | 2019-2025 | |
| Amgen INC. | $1,058.56 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $914.51 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $859.12 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $787.61 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $555.60 | 2019-2024 | Amplatzer Talisman, Amplatzer Amulet |
| Astrazeneca Pharmaceuticals LP | $541.65 | 2019-2025 | Farxiga, Wainua |
| Amarin Pharma, INC. | $534.02 | 2019-2022 | |
| Pfizer INC. | $456.77 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $443.54 | 2021-2025 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $335.38 | 2021-2025 | |
| Boston Scientific Corporation | $314.25 | 2019-2025 | Watchman Flx, Opticross, Vigilant X4 Crt-D |
| Sanofi-Aventis U.S. LLC | $270.05 | 2019-2023 | |
| Novo Nordisk INC | $234.42 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Alnylam Pharmaceuticals INC. | $199.13 | 2022-2025 | Onpattro |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $169.85 | 2019-2022 | |
| Esperion Therapeutics, INC. | $157.11 | 2020-2025 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $133.95 | 2019 | |
| Cardiac Dimensions, INC. | $131.69 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $128.63 | 2019-2025 | Lifevest |
| Insmed, INC. | $122.83 | 2019 | |
| Medtronic, INC. | $107.87 | 2022-2024 | Reveal Linq |
| Actelion Pharmaceuticals US, INC. | $94.86 | 2021-2023 | Opsumit |
| Bridgebio Pharma, INC. | $90.38 | 2025 | Attruby |
| Agepha Pharma Fz LLC | $90.38 | 2024-2025 | Lodoco |
| Abiomed | $76.40 | 2024-2025 | Impella |
| Scpharmaceuticals INC. | $74.31 | 2023-2024 | |
| Cvrx, INC. | $73.66 | 2024-2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals, LTD. | $66.27 | 2022-2023 | Arcalyst |
| Chiesi USA, INC. | $60.87 | 2019-2022 | |
| Philips North America LLC | $60.06 | 2022 | |
| Lundbeck LLC | $59.85 | 2019 | |
| Tactile Systems Technology INC | $48.55 | 2025 | Flexitouch Plus, Nimbl |
| Kiniksa Pharmaceuticals International, Plc | $48.04 | 2024 | Arcalyst |
| Lilly USA, LLC | $37.23 | 2025 | Zepbound |
| Lexicon Pharmaceuticals, INC. | $32.10 | 2024 | |
| Heartflow, INC. | $23.71 | 2023 | Ffrct |
| Cleerly, INC. | $22.72 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Vital Connect, INC | $21.79 | 2024 | Vitalpatch Rtm |
| Altathera Pharmaceuticals LLC | $20.44 | 2025 | Sotalol Hydrochloride |
| Kestra Medical Technology Services, INC. | $20.22 | 2024 | Assure Wcd |
| Silk Road Medical, INC. | $16.66 | 2019 | |
| Akcea Therapeutics, INC. | $15.70 | 2020 | |
| Medtronic Vascular, INC. | $15.66 | 2019 | |
| Ge Healthcare | $15.14 | 2021 | |
| Zoll Circulation INC | $15.00 | 2022 | |
| Cashflow Solutions, LLC | $14.03 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Htwe Sein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.